Citations (76)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Marco Galluzzo, Andrea Chiricozzi, Elisa Cinotti, Giovanna Brunasso, Maurizio Congedo, Maria Esposito, Chiara Franchi, Giovanna Malara, Alessandra Narcisi, Stefano Piaserico, Rossana Tiberio, Giuseppe Argenziano, Gabriella Fabbrocini & Aurora Parodi. (2022) Tildrakizumab for treatment of moderate to severe psoriasis: an expert opinion of efficacy, safety, and use in special populations. Expert Opinion on Biological Therapy 22:3, pages 367-376.
Read now
Read now
Yaser Ali, Fatemah Abutiban, Adel Alawadhi, Ali AlDei, Ahmad Alenizi, Hebah Alhajeri, Adeeba Al-Herz, Waleed Alkandari, Ahmad Dehrab, Eman Hasan, Sawsan Hayat, Aqeel Ghanem, Khulood Saleh & Xenofon Baraliakos. (2020) Recommendation for the Management of Spondyloarthritis Patients in Kuwait. Open Access Rheumatology: Research and Reviews 12, pages 147-165.
Read now
Read now
Mario Rivera-Izquierdo, Maria del Carmen Valero-Ubierna, Pelayo Nieto-Gómez, María Dolores Martínez-Bellón, Nicolás Francisco Fernández-Martínez & José Luis Barranco-Quintana. (2020) Vaccination in patients under monoclonal antibody treatment: an updated comprehensive review. Expert Review of Vaccines 19:8, pages 727-744.
Read now
Read now
Andreas Pinter, Bernd Bonnekoh, Ina Marion Hadshiew & Sebastian Zimmer. (2019) Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review. Clinical, Cosmetic and Investigational Dermatology 12, pages 509-517.
Read now
Read now
S. D’Adamio, D. Silvaggio, P. Lombardo, L. Bianchi, M. Talamonti & M. Galluzzo. (2019) The safety of anti-interleukins monoclonal antibodies for the treatment of psoriasis. Expert Opinion on Drug Safety 18:11, pages 1031-1041.
Read now
Read now
Annika Silfvast-Kaiser, So Yeon Paek & Alan Menter. (2019) Anti-IL17 therapies for psoriasis. Expert Opinion on Biological Therapy 19:1, pages 45-54.
Read now
Read now
M. Galluzzo, S. D’Adamio, E. Campione, L. Bianchi & M. Talamonti. (2018) A safety evaluation of guselkumab for the treatment of psoriasis. Expert Opinion on Drug Safety 17:7, pages 741-751.
Read now
Read now
Matteo Megna, Anna Balato, Annunziata Raimondo & Nicola Balato. (2018) Guselkumab for the treatment of psoriasis. Expert Opinion on Biological Therapy 18:4, pages 459-468.
Read now
Read now
Lauren Seale, Leah A. Cardwell & Steven R. Feldman. (2018) Adherence to biologics in patients with psoriasis. Expert Review of Clinical Immunology 14:2, pages 155-161.
Read now
Read now
Articles from other publishers (67)
Paolo Dapavo, Gabriella Fabbrocini, Elena Campione, Claudia Giofrè, Anna Balato, Concetta Potenza, Stefano Dastoli, Piergiorgio Malagoli, Annamaria Offidani, Federico Bardazzi, Ketty Peris, Paolo Pella, Rocco De Pasquale, Claudio Bonifati, Alfredo Giacchetti, Sabatino Pallotta, Maurizio Congedo, Paolo Amerio, Maria Concetta Fargnoli, Piergiacomo Calzavara Pinton & Marina Venturini. (2023) Achievement and maintenance of therapeutic response to brodalumab in patients with moderate‐to‐severe plaque psoriasis: An Italian, observational, retrospective and prospective study (BRIGHT study). JEADV Clinical Practice 2:4, pages 739-752.
Crossref
Crossref
Francois Rosset, Luca Mastorino, Paolo Dapavo, Michela Ortoncelli, Pietro Quaglino & Simone Ribero. (2023) Aging Impact in Response to Different Classes of Biological Treatment in Psoriatic Patients: A Real-Life Observational Study. Journal of Clinical Medicine 12:23, pages 7215.
Crossref
Crossref
Luca DEGLI ESPOSTI, Valentina PERRONE, Melania DOVIZIO, Diego SANGIORGI, Antonella DI CESARE, Elia ROSI, Ketty PERIS & Francesca PRIGNANO. (2023) Estimation of patients with psoriasis potentially eligible and currently untreated with biological drugs in Italy. Italian Journal of Dermatology and Venereology 158:6.
Crossref
Crossref
Mihaela Surcel, Carolina Constantin, Adriana Narcisa Munteanu, Diana Antonia Costea, Gheorghița Isvoranu, Elena Codrici, Ionela Daniela Popescu, Cristiana Tănase, Alef Ibram & Monica Neagu. (2023) Immune Portrayal of a New Therapy Targeting Microbiota in an Animal Model of Psoriasis. Journal of Personalized Medicine 13:11, pages 1556.
Crossref
Crossref
Luiz Euribel Prestes-Carneiro, Marilda Aparecida Milanez Morgado de Abreu, Eduardo Vinicius Mendes Roncada, Diego Garcia Muchon, Fernanda Miranda Caliani & Dewton Moraes Vasconcelos. (2023) Impact of Treatment with Ustekinumab on Severe Infections in a Patient with Uncontrolled Psoriasis and Late-Onset Combined Primary Immunodeficiency: Case Report. Pathogens 12:9, pages 1156.
Crossref
Crossref
Marijke Stryckers, Stefaan Van Oevelen, Priyanka Koshy, Ben Sprangers & Amaryllis H Van Craenenbroeck. (2023) Focal segmental glomerulosclerosis associated with the use of the IL-23 inhibitor guselkumab. Clinical Kidney Journal.
Crossref
Crossref
Weiqi Gao, Boran Yu, Ya Yan, Libo Zhao & Rongsheng Zhao. (2023) Comparation of time-course, dose-effect, influencing factors and adverse events of biologics in the treatment of adults with moderate to severe plaque psoriasis. Frontiers in Immunology 14.
Crossref
Crossref
Nouf Almuhanna, Bushra S Alasmari, Rasha Alhamazani, Sarah Alkhezzi & Faris A Alhomida. (2023) Assessing the Use of Ustekinumab in a Pediatric Patient With Harlequin Ichthyosis. Cureus.
Crossref
Crossref
Chieh-Shan Wu, Chuan-Chao Lin, Yu-Ying Chen & Deng-Ho Yang. (2022) Mechanisms and Effects of Isorhamnetin on Imiquimod-Induced Psoriasiform Dermatitis in Mice. Life 12:12, pages 2107.
Crossref
Crossref
Mohammad Mukim, Mohit Chaturvedi, Rakesh Patel, Supriya Roy, Pratishtha Sharma, Varunesh Chaturvedi, Saloni Goyal & Mohsina F. Patewkar. (2022) CROHN’S DISEASE: A REVIEW ON EPIDEMIOLOGY, DIAGNOSIS AND THERAPEUTIC MANAGEMENT. Indian Drugs 59:09, pages 16-28.
Crossref
Crossref
Menglin Liu, Zhen Wang, Jishou Zhang, Di Ye, Menglong Wang, Yao Xu, Mengmeng Zhao, Yongqi Feng, Xiyi Lu, Heng Pan, Wei Pan, Cheng Wei, Dan Tian, Wenqiang Li, Jingjun Lyu, Jing Ye & Jun Wan. (2022) IL-12p40 deletion aggravates lipopolysaccharide-induced cardiac dysfunction in mice. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Taehan Koo, Gayun Baek & Mihn‐Sook Jue. (2022)
Risk of tuberculosis infection and serial changes in
interferon‐gamma
release assays in elderly patients with psoriasis receiving biologic therapy
. The Journal of Dermatology 49:9, pages 887-894.
Crossref
Crossref
Saeideh Sadat Shobeiri, MohammadAli Rezaee, Safoora Pordel, Navideh Haghnnavaz, Mohammadreza Dashti, Malihe Moghadam & Mojtaba Sankian. (2022) Anti-IL-17A ssDNA aptamer ameliorated psoriasis skin lesions in the imiquimod-induced psoriasis mouse model. International Immunopharmacology 110, pages 108963.
Crossref
Crossref
Dohyen Wi, Anna Wilson, Fanny Satgé & Dédée F. Murrell. (2022) Psoriasis and osteoporosis: a literature review. Clinical and Experimental Dermatology 47:8, pages 1438-1445.
Crossref
Crossref
Mihaela Cristina Buhaș, Laura Ioana Gavrilaș, Rareș Candrea, Adrian Cătinean, Andrei Mocan, Doina Miere & Alexandru Tătaru. (2022) Gut Microbiota in Psoriasis. Nutrients 14:14, pages 2970.
Crossref
Crossref
Lanmei Lin, Yilun Wang, Xiaonian Lu, Tianxiao Wang, Qunyi Li, Runnan Wang, Jinfeng Wu, Jinhua Xu & Juan Du. (2022) The Inflammatory Factor SNP May Serve as a Promising Biomarker for Acitretin to Alleviate Secondary Failure of Response to TNF-a Monoclonal Antibodies in Psoriasis. Frontiers in Pharmacology 13.
Crossref
Crossref
Charmaine Kue Seguro, Michelle Demory Beckler & Marc M Kesselman. (2022) Targeting the NOD-, LRR- and Pyrin Domain-Containing Protein 3 (NLRP3) Inflammasome in Psoriasis and Fatigue. Cureus.
Crossref
Crossref
Huilin Wang, Wenjun Chen, Caihua Lie, Yijie Zhang, Jiajia Li, Jilong Meng & Nan Zhang. (2022) ARG1 and CXCL2 are potential biomarkers target for psoriasis patients. Molecular Pain 18, pages 174480692211284.
Crossref
Crossref
Kajal Rana, Trishna Pani, Somesh Kumar Jha, Devashish Mehta, Poonam Yadav, Dolly Jain, Manas Kumar Pradhan, Sarita Mishra, Raunak Kar, Betsy Reshma G, Aasheesh Srivastava, Ujjaini Dasgupta, Veena S. Patil & Avinash Bajaj. (2022)
Hydrogel-mediated topical delivery of steroids can effectively alleviate psoriasis
via
attenuating the autoimmune responses
. Nanoscale 14:10, pages 3834-3848.
Crossref
Crossref
Aina Akmal Mohd Noor, Maryam Azlan & Norhanani Mohd Redzwan. (2022) Orchestrated Cytokines Mediated by Biologics in Psoriasis and Its Mechanisms of Action. Biomedicines 10:2, pages 498.
Crossref
Crossref
Linda Davidson, Juul M.P.A. Van den Reek, Florence Van Hunsel, Elke M.G.J. De Jong & Bart Jan Kullberg. (2022) Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center. Acta Dermato-Venereologica 102, pages adv00648.
Crossref
Crossref
Qingqing Xu, Zhaoyang Liu, Zhiqiang Cao, Yongjian Shi, Ning Yang, Guangshang Cao, Chunmin Zhang, Rong Sun & Chunhong Zhang. (2022) Topical astilbin ameliorates imiquimod‐induced psoriasis‐like skin lesions in SKH‐1 mice via suppression dendritic cell‐Th17 inflammation axis. Journal of Cellular and Molecular Medicine 26:4, pages 1281-1292.
Crossref
Crossref
Charu Suri, Amit Awasthi & Shailendra Asthana. (2022) Crystallographic landscape provides molecular insights into the modes of action of diverse ROR-γt modulators. Drug Discovery Today 27:2, pages 652-663.
Crossref
Crossref
Mateusz Kamil Ożóg, Beniamin Oskar Grabarek, Magdalena Wierzbik-Strońska & Magdalena Świder. (2022) Neurological Complications of Biological Treatment of Psoriasis. Life 12:1, pages 118.
Crossref
Crossref
Andrea S. Franks, Bradley A. Boucher, Nancy Borja-Hart & J. Aubrey WaddellDaniel R. Malcom. 2022. The APhA Complete Review for Pharmacy, 13th Edition. The APhA Complete Review for Pharmacy, 13th Edition.
Maryam Akhtari. 2022. Ankylosing Spondylitis - Axial Spondyloarthritis. Ankylosing Spondylitis - Axial Spondyloarthritis
49
82
.
Touyana Semenova, Richard Witas, Brianna L. Schroeder, Katherine Bohn, Alexandria Voigt & Cuong Q. Nguyen. 2022. Handbook of Single-Cell Technologies. Handbook of Single-Cell Technologies
449
470
.
Martin Röcken, Beatrix Evers & Tilo Biedermann. 2022. Braun-Falco´s Dermatology. Braun-Falco´s Dermatology
23
34
.
Qingran Li, Weiping Liu, Shidong Gao, Yao Mao & Yanfei Xin. (2021) Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist. BMC Immunology 22:1.
Crossref
Crossref
Saeideh Sadat Shobeiri, Motahareh Khorrami & Mojtaba Sankian. (2021) Plaque-type psoriasis inhibitors. International Immunopharmacology 101, pages 108326.
Crossref
Crossref
Cristina Membrive Jiménez, Cristina Pérez Ramírez, Almudena Sánchez Martín, Sayleth Vieira Maroun, Salvador Arias Santiago, María Carmen Ramírez Tortosa & Alberto Jiménez Morales. (2021) Clinical Application of Pharmacogenetic Markers in the Treatment of Dermatologic Pathologies. Pharmaceuticals 14:9, pages 905.
Crossref
Crossref
Abdulmajeed M Alajlan & Tala A Qadoumi. (2021) Palmoplantar Psoriasis Successfully Treated With Risankizumab. Cureus.
Crossref
Crossref
Feras M. Ghazawi, Farhan Mahmood, Leon Kircik, Yves Poulin, Marc Bourcier, Ronald Vender, Marni C. Wiseman, Charles Lynde & Ivan V. Litvinov. (2021) A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on Tildrakizumab. Frontiers in Medicine 8.
Crossref
Crossref
Maryam Mardani, Hossein Mofidi, Ladan Dastgheib, Sara Ranjbar & Nasrin Hamidizadeh. (2021) Elevated Serum Interleukin-23 Levels in Patients with Oral and Cutaneous Lichen Planus. Mediators of Inflammation 2021, pages 1-6.
Crossref
Crossref
Rachel Addison, Sophie C. Weatherhead, Anandika Pawitri, Graham R. Smith, Ashley Rider, Henry J. Grantham, Simon J. Cockell & Nick J. Reynolds. (2021) Therapeutic wavelengths of ultraviolet B radiation activate apoptotic, circadian rhythm, redox signalling and key canonical pathways in psoriatic epidermis. Redox Biology 41, pages 101924.
Crossref
Crossref
Ajla Smajlović, Anja Haverić, Amer Alić, Maida Hadžić, Ahmed Smajlović, Indira Mujezinović, Naida Lojo-Kadrić, Jasmin Ramić, Nikolina Elez-Burnjaković, Sanin Haverić & Lejla Pojskić. (2021) Molecular and histopathological profiling of imiquimod induced dermatosis in Swiss Wistar rats: contribution to the rat model for novel anti-psoriasis treatments. Molecular Biology Reports 48:5, pages 4295-4303.
Crossref
Crossref
Cristina Membrive Jiménez, Cristina Pérez Ramírez, Almudena Sánchez Martín, Sayleth Vieira Maroun, Salvador Antonio Arias Santiago, María del Carmen Ramírez Tortosa & Alberto Jiménez Morales. (2021) Influence of Genetic Polymorphisms on Response to Biologics in Moderate-to-Severe Psoriasis. Journal of Personalized Medicine 11:4, pages 293.
Crossref
Crossref
Mahamudul Haque, Ruby J Siegel, David A Fox & Salahuddin Ahmed. (2021) Interferon-stimulated GTPases in autoimmune and inflammatory diseases: promising role for the guanylate-binding protein (GBP) family. Rheumatology 60:2, pages 494-506.
Crossref
Crossref
Hao Li & George C. Tsokos. (2020) IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases. Clinical Reviews in Allergy & Immunology 60:1, pages 31-45.
Crossref
Crossref
Arnaud Germain, Susan M. Levine & Maureen R. Hanson. (2021) In-Depth Analysis of the Plasma Proteome in ME/CFS Exposes Disrupted Ephrin-Eph and Immune System Signaling. Proteomes 9:1, pages 6.
Crossref
Crossref
Fernando Valenzuela & Rodrigo Flores. (2021) Immunogenicity to biological drugs in psoriasis and psoriatic arthritis. Clinics 76, pages e3015.
Crossref
Crossref
Jasmina Đuretić & Biljana Bufan. (2021) Safety and efficacy of interleukin inhibitors in elderly patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis. Arhiv za farmaciju 71:2, pages 101-119.
Crossref
Crossref
JIGANG LEI, ZHENYAO XU, SUKE LI, MENG LI, ZHIKAI WANG, PING LI, JING WANG, YINGLU CHEN, XIAOLE SONG, CHENGJIE REN, MEIPING SHEN & CHENGXIANG DAI. (2021) Human adipose, placenta, and umbilical cord-derived mesenchymal stem cells ameliorate imiquimod-induced psoriatic mice via reducing T cells infiltration. BIOCELL 45:3, pages 537-546.
Crossref
Crossref
Cristina Daniela Marineci, Cristina Elena Zbârcea, Cornel Chiriţă & Simona Negreş. (2021) Immunotherapeutics (II). Farmacist.ro 3:200, pages 7.
Crossref
Crossref
Caroline Nothdurfter, Vladimir M. Milenkovic, Nina Sarubin, Sven Hilbert, André Manook, Johannes Weigl, Khalifa Almeqbaali, Christian H. Wetzel, Rainer Rupprecht & Thomas C. Baghai. (2019) The cytokine IL‐17A as a marker of treatment resistance in major depressive disorder?. European Journal of Neuroscience 53:1, pages 172-182.
Crossref
Crossref
Vamshi Krishna Rapalli, Tejashree Waghule, Srividya Gorantla, Sunil Kumar Dubey, Ranendra Narayan Saha & Gautam Singhvi. (2020) Psoriasis: pathological mechanisms, current pharmacological therapies, and emerging drug delivery systems. Drug Discovery Today 25:12, pages 2212-2226.
Crossref
Crossref
Doreen M. Floss, Jens M. Moll & Jürgen Scheller. (2020) IL-12 and IL-23—Close Relatives with Structural Homologies but Distinct Immunological Functions. Cells 9:10, pages 2184.
Crossref
Crossref
Rhys D. R. Evans, Marilina Antonelou, Sanchutha Sathiananthamoorthy, Marilena Rega, Scott Henderson, Lourdes Ceron-Gutierrez, Gabriela Barcenas-Morales, Christoph A. Müller, Rainer Doffinger, Stephen B. Walsh & Alan D. Salama. (2020) Inherited salt-losing tubulopathies are associated with immunodeficiency due to impaired IL-17 responses. Nature Communications 11:1.
Crossref
Crossref
Xingli Li, Chenxian Ye, Mubarak Mulati, Lei Sun & Feng Qian. (2020) Ellipticine blocks synergistic effects of IL-17A and TNF-α in epithelial cells and alleviates severe acute pancreatitis-associated acute lung injury. Biochemical Pharmacology 177, pages 113992.
Crossref
Crossref
Eva Espinosa‐Cano, Maria Rosa Aguilar, Yadileiny Portilla, Domingo F. Barber & Julio San Román. (2020)
Polymeric Nanoparticles that Combine Dexamethasone and Naproxen for the Synergistic Inhibition of
Il12b
Transcription in Macrophages
. Macromolecular Bioscience 20:7.
Crossref
Crossref
Dae Hyun Ha, Hyun-keun Kim, Joon Lee, Hyuck Hoon Kwon, Gyeong-Hun Park, Steve Hoseong Yang, Jae Yoon Jung, Hosung Choi, Jun Ho Lee, Sumi Sung, Yong Weon Yi & Byong Seung Cho. (2020) Mesenchymal Stem/Stromal Cell-Derived Exosomes for Immunomodulatory Therapeutics and Skin Regeneration. Cells 9:5, pages 1157.
Crossref
Crossref
Huan Feng, Ruifang Wu, Suhan Zhang, Yi Kong, Zixin Liu, Haijing Wu, Honglin Wang, Yuwen Su, Ming Zhao & Qianjin Lu. (2019) Topical administration of nanocarrier miRNA‐210 antisense ameliorates imiquimod‐induced psoriasis‐like dermatitis in mice. The Journal of Dermatology 47:2, pages 147-154.
Crossref
Crossref
Arya Kadukkattil Ramanunny, Sheetu Wadhwa, Sachin Kumar Singh, Deep Shikha Sharma, Rubiya Khursheed & Ankit Awasthi. (2020) Treatment Strategies Against Psoriasis: Principle, Perspectives and Practices. Current Drug Delivery 17:1, pages 52-73.
Crossref
Crossref
C.Y. Erichsen, P. Jensen & K. Kofoed. (2019)
Biologic therapies targeting the interleukin (
IL
)‐23/
IL
‐17 immune axis for the treatment of moderate‐to‐severe plaque psoriasis: a systematic review and meta‐analysis
. Journal of the European Academy of Dermatology and Venereology 34:1, pages 30-38.
Crossref
Crossref
Romaine Stalder, Bin Zhang, Ludovic Jean Wrobel, Wolf‐Henning Boehncke & Nicolo Costantino Brembilla. (2019) The Janus Kinase inhibitor tofacitinib impacts human dendritic cell differentiation and favours M1 macrophage development. Experimental Dermatology 29:1, pages 71-78.
Crossref
Crossref
Martin Röcken, Beatrix Evers & Tilo Biedermann. 2020. Braun-Falco´s Dermatology. Braun-Falco´s Dermatology
1
12
.
Jenna Huld Eysteinsdóttir, Hildur Sigurgrímsdóttir, Helga Kristín Einarsdóttir, Jona Freysdottir, Bjarni A. Agnarsson, Jón Hjaltalín Ólafsson, Bárður Sigurgeirsson & Björn Rúnar Lúðvíksson. (2019) Effective treatment with balneophototherapy and narrowband UVB monotherapy reduces skin homing Th17/Tc17 and Th22/Tc22 effector cells in peripheral blood in patients with psoriasis. Journal of Dermatological Science 96:2, pages 110-112.
Crossref
Crossref
Elisabetta Bianchi & Lars Rogge. (2019) The IL-23/IL-17 pathway in human chronic inflammatory diseases – new insight from genetics and targeted therapies. Microbes and Infection 21:5-6, pages 246-253.
Crossref
Crossref
Carmen Rodríguez-Cerdeira, Mónica Cordeiro-Rodríguez, Miguel Carnero-Gregorio, Adriana López-Barcenas, Erick Martínez-Herrera, Gabriella Fabbrocini, Ardiana Sinani, Roberto Arenas-Guzmán & José Luís González-Cespón. (2019) Biomarkers of Inflammation in Obesity-Psoriatic Patients. Mediators of Inflammation 2019, pages 1-14.
Crossref
Crossref
Elisabetta Bianchi & Lars Rogge. (2019) The IL-23/IL-17 pathway in human chronic inflammatory diseases—new insight from genetics and targeted therapies. Genes & Immunity 20:5, pages 415-425.
Crossref
Crossref
Sree S. Kolli, Sarah D. Gabros, Adrian Pona, Abigail Cline & Steven R. Feldman. (2018) Tildrakizumab: A Review of Phase II and III Clinical Trials. Annals of Pharmacotherapy 53:4, pages 413-418.
Crossref
Crossref
James E. Frampton. (2019) Tildrakizumab: A Review in Moderate-to-Severe Plaque Psoriasis. American Journal of Clinical Dermatology 20:2, pages 295-306.
Crossref
Crossref
Touyana Semenova, Richard Witas, Brianna L. Schroeder, Katherine Bohn, Alexandria Voigt & Cuong Q. Nguyen. 2019. Handbook of Single Cell Technologies. Handbook of Single Cell Technologies
1
22
.
J. Posner, P. Barrington, T. Brier & A. Datta-Mannan. 2019. Concepts and Principles of Pharmacology. Concepts and Principles of Pharmacology
81
141
.
Jinling Ning, Ying Shen, Ting Wang, Mengru Wang, Wei Liu, Yonghu Sun, Furen Zhang, Lingling Chen & Yiqiang Wang. (2018) Altered expression of matrix remodelling associated 7 (MXRA7) in psoriatic epidermis: Evidence for a protective role in the psoriasis imiquimod mouse model. Experimental Dermatology 27:9, pages 1038-1042.
Crossref
Crossref
Nicole Cash. (2018) Psoriasis: From Gene to Clinic. EMJ Dermatology, pages 10-16.
Crossref
Crossref
Michael R. Pranzatelli. (2018) Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines. Frontiers in Immunology 9.
Crossref
Crossref